$42.95
−5.87%Year over year
Reported trailing growth
- Revenue
- +12.6%
- EBITDA
- +36.2%
- EBIT
- +38.3%
- EPS
- +131.7%
- Free cash flow
- +65.7%
- Operating cash flow
- +19.4%
Forward estimates
Based on analyst estimates
- Revenue
- +14.1%
- EBITDA
- -40.7%
- EPS
- +15.8%
Three-year CAGR
- Revenue
- -10.7%
- EBITDA
- -25.0%
- EBIT
- -29.8%
- Net income
- -44.0%
- EPS
- -40.1%
- Free cash flow
- -39.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026